Asia Green Biotechnology Corp.
Asia Green Biotechnology Corp.
Asia Green is an early stage international bio-technology company focused on the development, evaluation, testing, application and, ultimately, supply to the market of proprietary organic hybridization technology and certain products derived from that technology. The core approach of the business is centred on the planting, growth and harvesting of new and valuable strains of hemp and related crops in commercial quantities under the terms of license agreements with InPlanta Biotechnology Ltd., Swysh Inc. and Pathway RX Inc.
Asia Green Biotechnology Corp. (ASIA)
SEDAR Information
Company Info
Capitalization
News Releases
Press Release - April 12, 2024
Bulletins
2024-0234 - Halted for Fundamental Change - Asia Green Biotechnology Corp. (ASIA)
le 28 février/February 2024
Trading in the shares of Asia Green Biotechnology Corp. will remain halted pending receipt and review of acceptable documentation regarding the Fundamental Acquisition pursuant to CSE Policy 8. This regulatory halt is imposed by Canadian Investment Regulatory Organization, the Market Regulator of the Exchange, pursuant to the provisions of Section 10.9(1) of the Universal Market Integrity Rules.
